StockData
IN8bio, Inc. logo

IN8bio, Inc. (INAB) stock

INABNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.82+0.00 (+0.49%)

Close on Nov 17, 2026Market cap $8.08MP/E –Yield –

IN8bio price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

IN8bio's price to book ratio was 0.5× on Nov 11, 2026, against 0.7× a year earlier. Over the last 5 years it ranged from 0.4× to 4.5×, with a median of 1.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.5×−0.3
2025Dec 31, 20250.8×−0.6
2024Dec 31, 20241.4×−1.1
2023Dec 29, 20232.5×+0.6
2022Dec 30, 20221.9×+0.0
2021Dec 31, 20211.9×–

More IN8bio figures

See a number that looks wrong?